文献
J-GLOBAL ID:201802222550030777
整理番号:18A1153372
2型糖尿病患者における前向き無作為化試験(研究)の52週延長分析に対するエゼチミブ追加療法の効果【JST・京大機械翻訳】
Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects
著者 (12件):
Sakamoto Kentaro
(Department of Diabetes and Metabolism, Toho University Ohashi Medical Center, Tokyo, Japan)
,
Kawamura Mitsunobu
(Division of Endocrinology and Metabolism Department of Internal Medicine, Tokyo Teishin Hospital, Tokyo, Japan)
,
Watanabe Takayuki
(Department of Internal Medicine, Yokohama City Minato Red Cross Hospital, Tokyo, Japan)
,
Ashidate Keiko
(Department of Internal Medicine, Kudanzaka Hospital, Tokyo, Japan)
,
Kohro Takahide
(Department of Medical Informatics / Cardiology, Jichi Medical University, Tochigi, Japan)
,
Tanaka Akira
(Nutrition Clinic, Kagawa Nutrition University, Tokyo, Japan)
,
Mori Yasumichi
(Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan)
,
Tagami Motoki
(Sanraku Hospital, Life-style related Disease Clinic, Tokyo, Japan)
,
Hirano Tsutomu
(Department of Medicine Division of Diabetes Metabolism and Endocrinology, Showa University School of Medicine, Tokyo, Japan)
,
Yamazaki Tsutomu
(Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan)
,
Shiba Teruo
(Department of Diabetes and Metabolism, Toho University Ohashi Medical Center, Tokyo, Japan)
,
Shiba Teruo
(Division of Diabetes and Metabolism, Mitsui Memorial Hospital, Tokyo, Japan)
資料名:
Lipids in Health and Disease (Web)
(Lipids in Health and Disease (Web))
巻:
16
号:
1
ページ:
122
発行年:
2017年
JST資料番号:
U7391A
ISSN:
1476-511X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)